Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of …

Published October 31, 2013

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of …
The technology was developed by scientists at the University Health Network, the University of Toronto, through the Toronto Recombinant Antibody Centre (TRAC), and The Hospital for Sick Children (SickKids), in Toronto, Ontario. … Building on over … Read more on SYS-CON Media (press release)